Follow The Filings

GDRX GoodRx

GoodRx earnings company data as of 7:49 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.04 — —
Rev — — —

Insider trades

Open-market buys and sales by GDRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GDRX insider trades
  • None no insider bought on the open market
  • $9.7M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Francisco Partners Iv, L.P. 10% owner, +4 joint filers
    Sale
    $5.5M 1,567,044 shares at $3.50 100% of stake
    Traded Aug 24–26 Filed Aug 26
    ↗
  2. Francisco Partners Iv, L.P. 10% owner, +4 joint filers
    Sale
    $4.2M 1,193,951 shares at $3.52 61% of stake
    Traded Aug 19–21 Filed Aug 21
    ↗
  3. Spectrum Equity VII, L.P. 10% owner, +4 joint filers
    Sale
    $95K 23,771 shares at $4.00 100% of stake
    Traded Oct 15, 2025 Filed Oct 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 46 option exercises, 42 share withholdings for taxes, 14 stock grants, 2 conversions, 2 gifts, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 12 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.